332 related articles for article (PubMed ID: 15738667)
21. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells.
Bruder SP; Kurth AA; Shea M; Hayes WC; Jaiswal N; Kadiyala S
J Orthop Res; 1998 Mar; 16(2):155-62. PubMed ID: 9621889
[TBL] [Abstract][Full Text] [Related]
22. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice.
Lee JY; Musgrave D; Pelinkovic D; Fukushima K; Cummins J; Usas A; Robbins P; Fu FH; Huard J
J Bone Joint Surg Am; 2001 Jul; 83(7):1032-9. PubMed ID: 11451972
[TBL] [Abstract][Full Text] [Related]
23. Healing of large segmental bone defects induced by expedited bone morphogenetic protein-2 gene-activated, syngeneic muscle grafts.
Betz OB; Betz VM; Abdulazim A; Penzkofer R; Schmitt B; Schröder C; Augat P; Jansson V; Müller PE
Hum Gene Ther; 2009 Dec; 20(12):1589-96. PubMed ID: 19572783
[TBL] [Abstract][Full Text] [Related]
24. Escherichia coli-derived recombinant human bone morphogenetic protein-2 combined with bone marrow-derived mesenchymal stromal cells improves bone regeneration in canine segmental ulnar defects.
Itoi T; Harada Y; Irie H; Sakamoto M; Tamura K; Yogo T; Soeta S; Amasaki H; Hara Y; Tagawa M
BMC Vet Res; 2016 Sep; 12(1):201. PubMed ID: 27619812
[TBL] [Abstract][Full Text] [Related]
25. Enhanced osteoinduction by mesenchymal stem cells transfected with a fiber-mutant adenoviral BMP2 gene.
Tsuda H; Wada T; Yamashita T; Hamada H
J Gene Med; 2005 Oct; 7(10):1322-34. PubMed ID: 15926193
[TBL] [Abstract][Full Text] [Related]
26. Direct percutaneous gene delivery to enhance healing of segmental bone defects.
Betz OB; Betz VM; Nazarian A; Pilapil CG; Vrahas MS; Bouxsein ML; Gerstenfeld LC; Einhorn TA; Evans CH
J Bone Joint Surg Am; 2006 Feb; 88(2):355-65. PubMed ID: 16452748
[TBL] [Abstract][Full Text] [Related]
27. Autologous mesenchymal stem cells loaded in Gelfoam(®) for structural bone allograft healing in rabbits.
Lee JY; Choi MH; Shin EY; Kang YK
Cell Tissue Bank; 2011 Nov; 12(4):299-309. PubMed ID: 20652421
[TBL] [Abstract][Full Text] [Related]
28. The osteoinductive properties of Nell-1 in a rat spinal fusion model.
Lu SS; Zhang X; Soo C; Hsu T; Napoli A; Aghaloo T; Wu BM; Tsou P; Ting K; Wang JC
Spine J; 2007; 7(1):50-60. PubMed ID: 17197333
[TBL] [Abstract][Full Text] [Related]
29. In vivo evaluation of bone marrow stromal-derived osteoblasts-porous calcium phosphate ceramic composites as bone graft substitute for lumbar intervertebral spinal fusion.
Kai T; Shao-qing G; Geng-ting D
Spine (Phila Pa 1976); 2003 Aug; 28(15):1653-8. PubMed ID: 12897487
[TBL] [Abstract][Full Text] [Related]
30. Bone healing and migration of cord blood-derived stem cells into a critical size femoral defect after xenotransplantation.
Jäger M; Degistirici O; Knipper A; Fischer J; Sager M; Krauspe R
J Bone Miner Res; 2007 Aug; 22(8):1224-33. PubMed ID: 17451370
[TBL] [Abstract][Full Text] [Related]
31. Bone regeneration by implantation of adipose-derived stromal cells expressing BMP-2.
Li H; Dai K; Tang T; Zhang X; Yan M; Lou J
Biochem Biophys Res Commun; 2007 May; 356(4):836-42. PubMed ID: 17391646
[TBL] [Abstract][Full Text] [Related]
32. Tissue-engineered bone from BMP-2-transduced stem cells derived from human fat.
Dragoo JL; Lieberman JR; Lee RS; Deugarte DA; Lee Y; Zuk PA; Hedrick MH; Benhaim P
Plast Reconstr Surg; 2005 May; 115(6):1665-73. PubMed ID: 15861072
[TBL] [Abstract][Full Text] [Related]
33. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats.
Miyazaki M; Sugiyama O; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Virk MS; Lieberman JR; Wang JC
Spine (Phila Pa 1976); 2008 Jun; 33(13):1410-7. PubMed ID: 18475244
[TBL] [Abstract][Full Text] [Related]
34. Enhanced healing of goat femur-defect using BMP7 gene-modified BMSCs and load-bearing tissue-engineered bone.
Zhu L; Chuanchang D; Wei L; Yilin C; Jiasheng D
J Orthop Res; 2010 Mar; 28(3):412-8. PubMed ID: 19725097
[TBL] [Abstract][Full Text] [Related]
35. Recombinant human osteogenic protein-1 induces bone formation in a chronically infected, internally stabilized segmental defect in the rat femur.
Chen X; Schmidt AH; Tsukayama DT; Bourgeault CA; Lew WD
J Bone Joint Surg Am; 2006 Jul; 88(7):1510-23. PubMed ID: 16818977
[TBL] [Abstract][Full Text] [Related]
36. The effect of recombinant human bone morphogenetic protein-2 on femoral reconstruction with an intercalary allograft in a dog model.
Pluhar GE; Manley PA; Heiner JP; Vanderby R; Seeherman HJ; Markel MD
J Orthop Res; 2001 Mar; 19(2):308-17. PubMed ID: 11347706
[TBL] [Abstract][Full Text] [Related]
37. Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects.
Betz OB; Betz VM; Nazarian A; Egermann M; Gerstenfeld LC; Einhorn TA; Vrahas MS; Bouxsein ML; Evans CH
Gene Ther; 2007 Jul; 14(13):1039-44. PubMed ID: 17460719
[TBL] [Abstract][Full Text] [Related]
38. Structural and functional healing of critical-size segmental bone defects by transduced muscle-derived cells expressing BMP4.
Shen HC; Peng H; Usas A; Gearhart B; Fu FH; Huard J
J Gene Med; 2004 Sep; 6(9):984-91. PubMed ID: 15352071
[TBL] [Abstract][Full Text] [Related]
39. The association of human mesenchymal stem cells with BMP-7 improves bone regeneration of critical-size segmental bone defects in athymic rats.
Burastero G; Scarfì S; Ferraris C; Fresia C; Sessarego N; Fruscione F; Monetti F; Scarfò F; Schupbach P; Podestà M; Grappiolo G; Zocchi E
Bone; 2010 Jul; 47(1):117-26. PubMed ID: 20362702
[TBL] [Abstract][Full Text] [Related]
40. Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage.
Evans CH; Liu FJ; Glatt V; Hoyland JA; Kirker-Head C; Walsh A; Betz O; Wells JW; Betz V; Porter RM; Saad FA; Gerstenfeld LC; Einhorn TA; Harris MB; Vrahas MS
Eur Cell Mater; 2009 Dec; 18():96-111. PubMed ID: 20073015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
